Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate modelCentral MessagePerspective

Objectives: Palliative treatment of cyanotic congenital heart disease (CCHD) uses systemic-to-pulmonary conduits, often a modified Blalock–Taussig–Thomas shunt (mBTTs). Expanded polytetrafluoroethylene (ePTFE) mBTTs have associated risks for thrombosis and infection. The Human Acellular Vessel (HAV)...

Full description

Bibliographic Details

Published in:	JTCVS Open
Main Authors:	Kevin M. Nash, PhD, Brian A. Boe, MD, Sergio A. Carrillo, MD, Andrew Harrison, AS, ARRT, Ryuma Iwaki, MD, John Kelly, MD, Robert D. Kirkton, PhD, Ramkumar Krishnamurthy, PhD, Jeffrey H. Lawson, MD, PhD, Yuichi Matsuzaki, MD, PhD, Heather L. Prichard, PhD, Kejal Shah, MD, Toshiharu Shinoka, MD, PhD, Christopher K. Breuer, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Subjects:	congenital heart disease tissue-engineered vascular grafts Blalock–Taussig-Thomas shunt
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666273623002085